Not Tagged
Not Tagged
['doxorubicin', 'pomalidomide', 'lenalidomide', 'selinexor', 'borte', 'idecabtagene', 'daratumumab', 'mmsm', 'multiple myeloma', 'elotuzumab', 'panobinostat', 'belantamab,mafodotin', 'carfilzomib', 'belantamab', 'bortezomib', ' lena', 'thalidomide', 'ixazomib']
factors to consider include patient, disease &amp; treatment. new therapies continue to be fda approved. ndmm treatment landscape starts with tx eligible or ineligible, both w/goals to get rapid disease effect w/limited ae.
#ash22 #mmsm #myeloma 
Hematology is in my ??. Posts are mine. Mayo Clinic Associate, Asst Prof, BMT RNCC, RN Navigator, emeritus. IMF NLB. MM KOL. Patient educator & advocate.